,31 In prostate cancer, PKD3 significantly promotes tumor cell proliferation by modulating FASN and ACLY expression and de novo lipid synthesis in an SREBP1-dependent manner (Fig. 2).32 The gene discussed is ACLY; the disease is neoplasm.